VSMD (Vasamed) EBIT: $-4.63 Mil (TTM As of Sep. 2006)


What is Vasamed EBIT?

Vasamed VSMD EBIT is $-4.63 Mil as of Sep. 2006.

Vasamed's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2006 was $-1.24 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2006 was $-4.63 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vasamed's annualized ROC % for the quarter that ended in Sep. 2006 was -207.39%. Vasamed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2006 was -1,660.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Vasamed  (OTCPK:VSMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vasamed's annualized ROC % for the quarter that ended in Sep. 2006 is calculated as:

ROC % (Q: Sep. 2006 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2006 ) + Invested Capital (Q: Sep. 2006 ))/ count )
=-4.94 * ( 1 - % )/( (2.284 + 2.48)/ 2 )
=-4.94/2.382
=-207.39 %

where

Invested Capital(Q: Jun. 2006 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.254 - 0.379 - ( 0.952 - max(0, 1.372 - 1.963+0.952))
=2.284

Invested Capital(Q: Sep. 2006 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.08 - 0.457 - ( 0.625 - max(0, 1.548 - 1.691+0.625))
=2.48

Note: The Operating Income data used here is four times the quarterly (Sep. 2006) data.

2. Joel Greenblatt's definition of Return on Capital:

Vasamed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2006 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2006 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2006  Q: Sep. 2006
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.94/( ( (0.287 + max(-0.056, 0)) + (0.308 + max(-0.475, 0)) )/ 2 )
=-4.94/( ( 0.287 + 0.308 )/ 2 )
=-4.94/0.2975
=-1,660.50 %

where Working Capital is:

Working Capital(Q: Jun. 2006 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.433 + 0.542 + 0.036) - (0.379 + 0 + 0.688)
=-0.056

Working Capital(Q: Sep. 2006 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.324 + 0.703 + 0.039) - (0.457 + 0 + 1.084)
=-0.475

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2006) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vasamed's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2006 )
=-4.627/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed EBIT Related Terms

Vasamed EBIT Historical Data

* Premium members only.

The historical data trend for Vasamed's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed EBIT Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.73 -1.88 -2.29 -6.30 -4.74

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.59 -0.97 -1.19 -1.24 -1.24

VSMD vs LENSF, WHSI, ASNB: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Vasamed's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vasamed EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vasamed's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vasamed's EV-to-EBIT falls into.


Vasamed EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-4.63 Mil mean?
Vasamed (VSMD) has a EBIT of $-4.63 Mil as of Sep. 2006. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vasamed.
Is Vasamed's EBIT too high?
Vasamed's current EBIT is $-4.63 Mil.
How does Vasamed's EBIT compare to LENSF and WHSI?
Vasamed's EBIT of $-4.63 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vasamed. Vasamed's current EBIT is $-4.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasamed stock overvalued right now?
Vasamed (VSMD) has a current EBIT of $-4.63 Mil. The current EBIT is $-4.63 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Vasamed (VSMD), the current EBIT is $-4.63 Mil as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vasamed Business Description

Address 7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.